ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 67 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $297,000 | -71.9% | 114,240 | -58.0% | 0.00% | -75.0% |
| Q3 2016 | $1,057,000 | +44.6% | 271,770 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $731,000 | -12.7% | 271,770 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $837,000 | -20.0% | 271,770 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $1,046,000 | +26.2% | 271,770 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $829,000 | -39.0% | 271,770 | -15.1% | 0.00% | -40.0% |
| Q2 2015 | $1,358,000 | +9.9% | 320,170 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $1,236,000 | -40.0% | 320,170 | +4.6% | 0.00% | -42.9% |
| Q4 2014 | $2,060,000 | +22.6% | 306,070 | 0.0% | 0.01% | +16.7% |
| Q3 2014 | $1,680,000 | -4.3% | 306,070 | +78.7% | 0.01% | 0.0% |
| Q2 2014 | $1,756,000 | -14.6% | 171,270 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $2,057,000 | +12.5% | 171,270 | +5.9% | 0.01% | +14.3% |
| Q4 2013 | $1,828,000 | +64.4% | 161,670 | +56.6% | 0.01% | +40.0% |
| Q3 2013 | $1,112,000 | – | 103,270 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |